Amundi Edgewise Therapeutics, Inc. Transaction History
Amundi
- $275 Billion
- Q4 2024
A detailed history of Amundi transactions in Edgewise Therapeutics, Inc. stock. As of the latest transaction made, Amundi holds 341,687 shares of EWTX stock, worth $9.26 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
341,687
Previous 150,420
127.16%
Holding current value
$9.26 Million
Previous $4.01 Million
127.28%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding EWTX
# of Institutions
215Shares Held
98.3MCall Options Held
885KPut Options Held
232K-
Orbimed Advisors LLC San Diego, CA15MShares$407 Million10.86% of portfolio
-
Ra Capital Management, L.P. Boston, MA8.91MShares$241 Million3.85% of portfolio
-
Baker Bros. Advisors LP New York, NY6.16MShares$167 Million1.82% of portfolio
-
Black Rock Inc. New York, NY6.02MShares$163 Million0.0% of portfolio
-
Novo Holdings Hellerup, G75MShares$136 Million10.85% of portfolio
About Edgewise Therapeutics, Inc.
- Ticker EWTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 63,171,700
- Market Cap $1.71B
- Description
- Edgewise Therapeutics, Inc., a biopharmaceutical company, develops small molecule therapies for musculoskeletal diseases. The Company's lead product candidate, EDG-5506, is an orally administered small molecule designed to address the root cause of dystrophinopathies including Duchenne muscular dystrophy and Becker muscular dystrophy which has c...